Nabla Bio

A drug design company pairing generative protein models with large-scale wet-lab testing to make antibody discovery a design discipline.

Location: Cambridge, Massachusetts, United States

1 model

Models (1)

Nabla Bio

Released January 21, 2025

———

Generative de novo antibody design system jointly modeling sequence and all-atom structure, refined by scaling test-time compute.

Protein